Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome.

Sollini M, di Tommaso L, Kirienko M, Piombo C, Erreni M, Lania AG, Erba PA, Antunovic L, Chiti A.

EJNMMI Res. 2019 Oct 15;9(1):93. doi: 10.1186/s13550-019-0559-9.

2.

Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss.

Menale C, Robinson LJ, Palagano E, Rigoni R, Erreni M, Almarza AJ, Strina D, Mantero S, Lizier M, Forlino A, Besio R, Monari M, Vezzoni P, Cassani B, Blair HC, Villa A, Sobacchi C.

J Bone Miner Res. 2019 Jul 11. doi: 10.1002/jbmr.3829. [Epub ahead of print]

PMID:
31295380
3.

Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism.

Mazzoni M, Mauro G, Erreni M, Romeo P, Minna E, Vizioli MG, Belgiovine C, Rizzetti MG, Pagliardini S, Avigni R, Anania MC, Allavena P, Borrello MG, Greco A.

J Exp Clin Cancer Res. 2019 May 21;38(1):208. doi: 10.1186/s13046-019-1198-8.

4.

TNF-Stimulated Gene-6 Is a Key Regulator in Switching Stemness and Biological Properties of Mesenchymal Stem Cells.

Romano B, Elangovan S, Erreni M, Sala E, Petti L, Kunderfranco P, Massimino L, Restelli S, Sinha S, Lucchetti D, Anselmo A, Colombo FS, Stravalaci M, Arena V, D'Alessio S, Ungaro F, Inforzato A, Izzo AA, Sgambato A, Day AJ, Vetrano S.

Stem Cells. 2019 Jul;37(7):973-987. doi: 10.1002/stem.3010. Epub 2019 May 14.

PMID:
30942926
5.

3D Bone Biomimetic Scaffolds for Basic and Translational Studies with Mesenchymal Stem Cells.

Sobacchi C, Erreni M, Strina D, Palagano E, Villa A, Menale C.

Int J Mol Sci. 2018 Oct 13;19(10). pii: E3150. doi: 10.3390/ijms19103150. Review.

6.

Mesenchymal Stromal Cell-Seeded Biomimetic Scaffolds as a Factory of Soluble RANKL in Rankl-Deficient Osteopetrosis.

Menale C, Campodoni E, Palagano E, Mantero S, Erreni M, Inforzato A, Fontana E, Schena F, Van't Hof R, Sandri M, Tampieri A, Villa A, Sobacchi C.

Stem Cells Transl Med. 2019 Jan;8(1):22-34. doi: 10.1002/sctm.18-0085. Epub 2018 Sep 5.

7.

Optical in vivo imaging detection of preclinical models of gut tumors through the expression of integrin αVβ3.

Marelli G, Avigni R, Allavena P, Garlanda C, Mantovani A, Doni A, Erreni M.

Oncotarget. 2018 Jul 31;9(59):31380-31396. doi: 10.18632/oncotarget.25826. eCollection 2018 Jul 31.

8.

The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity.

Filipello F, Morini R, Corradini I, Zerbi V, Canzi A, Michalski B, Erreni M, Markicevic M, Starvaggi-Cucuzza C, Otero K, Piccio L, Cignarella F, Perrucci F, Tamborini M, Genua M, Rajendran L, Menna E, Vetrano S, Fahnestock M, Paolicelli RC, Matteoli M.

Immunity. 2018 May 15;48(5):979-991.e8. doi: 10.1016/j.immuni.2018.04.016. Epub 2018 May 8.

9.

Inhalation of peptide-loaded nanoparticles improves heart failure.

Miragoli M, Ceriotti P, Iafisco M, Vacchiano M, Salvarani N, Alogna A, Carullo P, Ramirez-Rodríguez GB, Patrício T, Esposti LD, Rossi F, Ravanetti F, Pinelli S, Alinovi R, Erreni M, Rossi S, Condorelli G, Post H, Tampieri A, Catalucci D.

Sci Transl Med. 2018 Jan 17;10(424). pii: eaan6205. doi: 10.1126/scitranslmed.aan6205.

PMID:
29343624
10.

Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition.

Siddiqui I, Erreni M, Kamal MA, Porta C, Marchesi F, Pesce S, Pasqualini F, Schiarea S, Chiabrando C, Mantovani A, Allavena P.

Oncoimmunology. 2017 Nov 1;7(2):e1388485. doi: 10.1080/2162402X.2017.1388485. eCollection 2018.

11.

An autofluorescence-based method for the isolation of highly purified ventricular cardiomyocytes.

Larcher V, Kunderfranco P, Vacchiano M, Carullo P, Erreni M, Salamon I, Colombo FS, Lugli E, Mazzola M, Anselmo A, Condorelli G.

Cardiovasc Res. 2018 Mar 1;114(3):409-416. doi: 10.1093/cvr/cvx239.

PMID:
29244142
12.

The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis.

Erreni M, Manfredi AA, Garlanda C, Mantovani A, Rovere-Querini P.

Immunol Rev. 2017 Nov;280(1):112-125. doi: 10.1111/imr.12570. Review.

PMID:
29027216
13.

Targeting tumor associated macrophages: The new challenge for nanomedicine.

Andón FT, Digifico E, Maeda A, Erreni M, Mantovani A, Alonso MJ, Allavena P.

Semin Immunol. 2017 Dec;34:103-113. doi: 10.1016/j.smim.2017.09.004. Epub 2017 Sep 21. Review.

PMID:
28941641
14.

Heme-oxygenase-1 Production by Intestinal CX3CR1+ Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis.

Marelli G, Erreni M, Anselmo A, Taverniti V, Guglielmetti S, Mantovani A, Allavena P.

Cancer Res. 2017 Aug 15;77(16):4472-4485. doi: 10.1158/0008-5472.CAN-16-2501. Epub 2017 Jun 15.

15.

Non-redundant role of the chemokine receptor CX3CR1 in the anti-inflammatory function of gut macrophages.

Marelli G, Belgiovine C, Mantovani A, Erreni M, Allavena P.

Immunobiology. 2017 Feb;222(2):463-472. doi: 10.1016/j.imbio.2016.07.013. Epub 2016 Aug 2.

PMID:
27707514
16.

Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.

Di Caro G, Carvello M, Pesce S, Erreni M, Marchesi F, Todoric J, Sacchi M, Montorsi M, Allavena P, Spinelli A.

PLoS One. 2016 May 26;11(5):e0156669. doi: 10.1371/journal.pone.0156669. eCollection 2016.

17.

Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model.

Garetto S, Sardi C, Martini E, Roselli G, Morone D, Angioni R, Cianciotti BC, Trovato AE, Franchina DG, Castino GF, Vignali D, Erreni M, Marchesi F, Rumio C, Kallikourdis M.

Oncotarget. 2016 Jul 12;7(28):43010-43026. doi: 10.18632/oncotarget.9280.

18.

Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.

Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P.

J Immunother Cancer. 2016 Apr 19;4:21. doi: 10.1186/s40425-016-0125-1. eCollection 2016.

19.

Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.

Di Caro G, Carvello M, Pesce S, Erreni M, Marchesi F, Todoric J, Sacchi M, Montorsi M, Allavena P, Spinelli A.

PLoS One. 2016 Feb 9;11(2):e0148186. doi: 10.1371/journal.pone.0148186. eCollection 2016. Erratum in: PLoS One. 2016;11(5):e0156669.

20.

The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.

Erreni M, Siddiqui I, Marelli G, Grizzi F, Bianchi P, Morone D, Marchesi F, Celesti G, Pesce S, Doni A, Rumio C, Roncalli MG, Laghi L, Mantovani A, Allavena P.

J Immunol. 2016 Jan 15;196(2):902-14. doi: 10.4049/jimmunol.1501335. Epub 2015 Dec 16.

21.

Macrophage polarization in pathology.

Sica A, Erreni M, Allavena P, Porta C.

Cell Mol Life Sci. 2015 Nov;72(21):4111-26. doi: 10.1007/s00018-015-1995-y. Epub 2015 Jul 26. Review.

PMID:
26210152
22.
23.

Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.

Erreni M, Mantovani A, Allavena P.

Cancer Microenviron. 2011 Aug;4(2):141-54. doi: 10.1007/s12307-010-0052-5. Epub 2010 Sep 17.

24.

Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1.

Erreni M, Solinas G, Brescia P, Osti D, Zunino F, Colombo P, Destro A, Roncalli M, Mantovani A, Draghi R, Levi D, Rodriguez Y Baena R, Gaetani P, Pelicci G, Allavena P.

Eur J Cancer. 2010 Dec;46(18):3383-92. doi: 10.1016/j.ejca.2010.07.022. Epub 2010 Aug 19.

PMID:
20728344
25.

Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.

Marchesi F, Locatelli M, Solinas G, Erreni M, Allavena P, Mantovani A.

J Neuroimmunol. 2010 Jul 27;224(1-2):39-44. doi: 10.1016/j.jneuroim.2010.05.007. Epub 2010 Jul 13. Review.

PMID:
20630606
26.

Expression of chemokines and chemokine receptors in human colon cancer.

Erreni M, Bianchi P, Laghi L, Mirolo M, Fabbri M, Locati M, Mantovani A, Allavena P.

Methods Enzymol. 2009;460:105-21. doi: 10.1016/S0076-6879(09)05205-7.

PMID:
19446722
27.

RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors.

De Falco V, Guarino V, Malorni L, Cirafici AM, Troglio F, Erreni M, Pelicci G, Santoro M, Melillo RM.

Oncogene. 2005 Sep 15;24(41):6303-13.

PMID:
15940252

Supplemental Content

Loading ...
Support Center